NIAID (National Institute of Allergy and Infectious Diseases)
Scientific/Medical Group Awards
HPTN 083 & HPTN 084 Clinical Trial Team
In recognition of exceptional conduct of the HPTN 083 & HPTN 084 clinical trials that resulted in FDA approval of Cabotegravir Long Acting (CAB LA).
Administrative Group Awards
Ending the HIV Epidemic Team
For extraordinary dedication and teamwork in supporting the Department of Health and Human Service's Ending the HIV Epidemic initiative to inform best practices through research.
Public Health Service Commissioned Corps Awards
Outstanding Service Medal
Outstanding Service Medal Individual Awards
For scientific leadership in HPTN 083 & 084 resulting in the licensure of long acting Cabotegravir as APRETUDE by the FDA for HIV pre-exposure prophylaxis.